Skip to main content
. 2022 May 12;10(5):770. doi: 10.3390/vaccines10050770
cpe cytopathic effect
CRE-2C cis-acting replication element
CVB3 coxsackievirus B3
CVB3-TDn CVB3 TD with 5′ nucleotide n
DCM dilated cardiomyopathy
DI defective interfering
hnRNP-C heterogeneous nuclear ribonucleoprotein C
IHC immunohistochemistry
IRES internal ribosome entry site
ISH in situ hybridization
MOI multiplicity of infection
NTR nontranslated region
ORF open reading frame
P1 capsid coding
PCBP2 polyC-binding protein 2
p.i. post-inoculation
PV poliovirus
RACE rapid amplification of cDNA ends
RI replication intermediate
RF replicative form
RT-PCR reverse transcription-polymerase chain reaction
TD 5′ terminal deletions
T1D type 1 diabetes